American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

RSS icon
New data from the American Heart Association (AHA), published Jan. 25, 2023, in Circulation, suggests it resulted in a significant increase in the number of patients dying from cardiovascular disease (CVD) and a higher age-adjusted mortality rate. Oxygen Mask

COVID-19 caused CVD deaths in the U.S. to spike, new research confirms

Researchers explored updated data from the AHA, noting that the number of CVD-related deaths increased from more than 874,000 in 2019 to more than 928,000 in 2020.

January 25, 2023

Why more pulmonary embolism patients should be considered for surgery

The topic was explored at length in a new scientific statement presented at the 59th Annual Meeting of the Society of Thoracic Surgeons.

January 23, 2023

AHA: ‘Mini strokes’ need emergency assessment, may require hospitalization

Even if symptoms disappear quickly, a transient ischemic attack can be a major short-term risk indicator.

January 20, 2023

Intermittent fasting not associated with long-term weight loss, according to new 6-year analysis

Reducing total calorie intake and minimizing large meals, on the other hand, were both linked to improved weight loss. The study followed participants for an average of 6.3 years. 

January 18, 2023
Tablet projecting metaphorical medical hologram

EHR intervention targets acute kidney injuries after PCI

Contrast-associated acute kidney injury is a significant problem in cardiology, especially among patients undergoing percutaneous coronary intervention. Can EHR-generated alerts make an impact?

January 18, 2023
Peter Libby, MD, a cardiovascular medicine specialist, Brigham and Women’s Hospital, and Mallinckrodt Professor of Medicine, Harvard Medical School, explains the take aways from the PROMINENT trial using pemafibrate to lower cardiovascular risks. The trial, presented at the American Heart Association (AHA) 2022 meeting, did not show reduction in the incidence of cardiovascular events among those who received pemafibrate than among those who received placebo. #AHA #AHA22

VIDEO: Pemafibrate does not lower cardiovascular risks in the PROMINENT trial

Peter Libby, MD, a cardiovascular medicine specialist with Brigham and Women’s Hospital and Harvard Medical School, explained some key takeaways from the PROMINENT trial.

January 17, 2023
The 120,000-square-foot advanced outpatient care center on the 4800 block of South Cottage Grove Avenue is expected to serve more than 50,000 patients annually from Bronzeville and nearby communities. Northwestern also wants to try and staff the majority of the clinic with clinicians who are Black to better reflect the community they will be serving. Construction could begin in summer 2023, with a scheduled opening in summer of 2025.

VIDEO: Northwestern plans to open Chicago South Side clinic to address healthcare access

Northwestern's Clyde Yancy, MD, discusses how his health system is addressing health access equity issues with plans to open a new outpatient clinic on the historically Black Chicago South Side.

January 13, 2023

Elevated uric acid levels linked to new-onset AFib

According to new data published in the Journal of the American Heart Association, atrial fibrillation can be added to the list of cardiovascular conditions associated with above-average uric acid levels. 

January 13, 2023
Displaying 57 - 64 of 154
Design by Adaptive Theme